356 related articles for article (PubMed ID: 7524683)
1. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
[TBL] [Abstract][Full Text] [Related]
2. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Pandya PK; Huang SC; Talkad VD; Wank SA; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):117-26. PubMed ID: 7948036
[TBL] [Abstract][Full Text] [Related]
3. Direct demonstration of three different states of the pancreatic cholecystokinin receptor.
Talkad VD; Fortune KP; Pollo DA; Shah GN; Wank SA; Gardner JD
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1868-72. PubMed ID: 8127897
[TBL] [Abstract][Full Text] [Related]
4. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.
Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684
[TBL] [Abstract][Full Text] [Related]
5. Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells.
Vinayek R; Patto RJ; Menozzi D; Gregory J; Mrozinski JE; Jensen RT; Gardner JD
Biochim Biophys Acta; 1993 Mar; 1176(1-2):183-91. PubMed ID: 7680902
[TBL] [Abstract][Full Text] [Related]
6. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
Yule DI; Williams JA
Peptides; 1994; 15(6):1045-51. PubMed ID: 7527529
[TBL] [Abstract][Full Text] [Related]
7. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
9. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180.
Matozaki T; Göke B; Tsunoda Y; Rodriguez M; Martinez J; Williams JA
J Biol Chem; 1990 Apr; 265(11):6247-54. PubMed ID: 1690723
[TBL] [Abstract][Full Text] [Related]
10. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a persistent inhibitory action of L-364,718 on cholecystokinin-stimulated enzyme secretion in pancreatic acini.
Bhat ST; Talkad VD; Pollo DA; Gardner JD
Pancreas; 1994 Jan; 9(1):101-8. PubMed ID: 7509060
[TBL] [Abstract][Full Text] [Related]
13. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
14. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
[TBL] [Abstract][Full Text] [Related]
16. Multiple affinity states of different cholecystokinin receptors.
Huang SC; Fortune KP; Wank SA; Kopin AS; Gardner JD
J Biol Chem; 1994 Oct; 269(42):26121-6. PubMed ID: 7929324
[TBL] [Abstract][Full Text] [Related]
17. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
Nozu F; Tsunoda Y; Ibitayo AI; Bitar KN; Owyang C
Am J Physiol; 1999 Apr; 276(4):G915-23. PubMed ID: 10198335
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.
Blevins GT; van de Westerlo EM; Williams JA
Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749
[TBL] [Abstract][Full Text] [Related]
20. High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion.
Tsunoda Y; Owyang C
Am J Physiol; 1995 Sep; 269(3 Pt 1):G435-44. PubMed ID: 7573455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
